Minimizing eyyoys of omission:: Behaviouyal rEenforcement of Heparin to Aveyt Venous Emboli:: The BEHAVE Study

被引:51
作者
McMullin, J [1 ]
Cook, D
Griffith, L
McDonald, E
Clarke, F
Guyatt, G
Gibson, J
Crowther, M
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
关键词
D O I
10.1097/01.CCM.0000201886.84135.CB
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To improve patient safety by increasing heparin thromboprophylaxis for medical-surgical intensive care unit patients using a multiple-method approach to evidence-based guideline development and implementation. Design: Prospective longitudinal observational study. Setting. Medical-surgical intensive care unit. Participants. Multidisciplinary clinicians caring for critically ill patients in a 15-bed medical-surgical closed intensive care unit. Interventions. Phase 1 was a 3-month baseline period during which we documented anticoagulation and mechanical thromboprophylaxis. Phase 2 was a 1-yr period in which we implemented a thromboprophylaxis guideline using a) interactive multidisciplinary educational in-services; b) verbal reminders to the intensive care unit team; c) computerized daily nurse recording of thromboprophylaxis; d) weekly graphic feedback to individual intensivists on guideline adherence; and e) publicly displayed graphic feedback on group performance. Phase 3 was a 3-month follow-up period 10 months later, during which we documented thromboprophylaxis. Computerized daily nurse recording of thromboprophylaxis continued in this period. Measurements and Main Results: Intensive care unit and hospital mortality rates were similar across phases, although patients in phase 2 had higher Acute Physiology and Chronic Health Evaluation II scores than patients in phases 1 and 3. The proportion (median % [interquartile range]) of intensive care unit patient-days of heparin thromboprophylaxis in phases 1, 2, and 3 was 60.0 (0, 100), 90.9 (50, 100), and 100.0 (60, 100), respectively (p =.01). The proportion (median % [interquartile range]) of days during which heparin thromboprophylaxis was omitted in error in phases 1, 2, and 3 was 20 (0, 53.8), 0 (0, 6.3), and 0 (0, 0), respectively (p <.001). Conclusions. After development and implementation of an evidence-based thromboprophylaxis guideline, we found significantly more patients receiving heparin thromboprophylaxis. Guideline adherence was maintained 1 yr later. Further research is needed on which are the most effective strategies to implement patient safety initiatives in the intensive care unit.
引用
收藏
页码:694 / 699
页数:6
相关论文
共 35 条
  • [1] EFFICACY AND COST OF LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH STANDARD HEPARIN FOR THE PREVENTION OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP-ARTHROPLASTY
    ANDERSON, DR
    OBRIEN, BJ
    LEVINE, MN
    ROBERTS, R
    WELLS, PS
    HIRSH, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) : 1105 - 1112
  • [2] Missed opportunities for prevention of venous thromboembolism - An evaluation of the use of thromboprophylaxis guidelines
    Arnold, DA
    Kahn, SR
    Shrier, I
    [J]. CHEST, 2001, 120 (06) : 1964 - 1971
  • [3] Deep vein thrombosis and its prevention in critically ill adults
    Attia, J
    Ray, JG
    Cook, DJ
    Douketis, J
    Ginsberg, JS
    Geerts, WH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (10) : 1268 - 1279
  • [4] Bero LA, 1998, BMJ-BRIT MED J, V317, P465
  • [5] The radiological investigation of suspected lower limb deep vein thrombosis
    Burn, PR
    Blunt, DM
    Sansom, HE
    Phelan, MS
    [J]. CLINICAL RADIOLOGY, 1997, 52 (08) : 625 - 628
  • [6] Why don't physicians follow clinical practice guidelines? A framewouk for improvement
    Cabana, MD
    Rand, CS
    Powe, NR
    Wu, AW
    Wilson, MH
    Abboud, PAC
    Rubin, HR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15): : 1458 - 1465
  • [7] HIGH-RISK OF THE CRITICALLY ILL FOR VENOUS THROMBOEMBOLISM
    CADE, JF
    [J]. CRITICAL CARE MEDICINE, 1982, 10 (07) : 448 - 450
  • [8] Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors
    Cook, D
    Crowther, M
    Meade, M
    Rabbat, C
    Griffith, L
    Schiff, D
    Geerts, W
    Guyatt, G
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (07) : 1565 - 1571
  • [9] Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients
    Cook, D
    Attia, J
    Weaver, B
    McDonald, E
    Meade, M
    Crowther, M
    [J]. JOURNAL OF CRITICAL CARE, 2000, 15 (04) : 127 - 132
  • [10] Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey
    Cook, D
    McMullin, J
    Hodder, R
    Heule, M
    Pinilla, J
    Dodek, P
    Stewart, T
    [J]. CRITICAL CARE, 2001, 5 (06): : 336 - 342